A Nobel Discovery
…efficacy by slowing down its degradation. Clinical trial recruitment for an mRNA vaccine against rabies began in 2016, and additional trials for vaccines against influenza virus, cytomegalovirus, Zika virus, and…
…efficacy by slowing down its degradation. Clinical trial recruitment for an mRNA vaccine against rabies began in 2016, and additional trials for vaccines against influenza virus, cytomegalovirus, Zika virus, and…
…Dr. Joshua Stillman to talk about passive antibody therapy for Nipah infection in ferrets, annual influenza immunization of children, facemasks to prevent influenza, predicting dengue outbreaks by the weather, and…
…influenza A and 285 (25%) were influenza B. Of the influenza A virus positive specimens, 4 were H1N1 (2009) and 406 contained the H3 HA. The remainder (444) were not…
…or listen on your mobile device with the Microbeworld app. Links for this episode: ACAM2000 smallpox vaccine Bavarian Nordic’s smallpox vaccine Imvamune and phase II trial Rich and Ed’s paper…
…the world will have to switch to using inactivated poliovaccine. Related: Wild poliovirus in China Dreaming of inactivated poliovaccine Poliomyelitis after a twelve year incubation period Poliovirus vaccine litigation …
…Recently a dengue virus vaccine called Dengvaxxia was approved for use in Brazil, Mexico, and the Philippines. However, the vaccine is not licensed for use in children less than 9…